Özge Alper

473 total citations
12 papers, 365 citations indexed

About

Özge Alper is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Özge Alper has authored 12 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Özge Alper's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cell Adhesion Molecules Research (3 papers). Özge Alper is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cell Adhesion Molecules Research (3 papers). Özge Alper collaborates with scholars based in United States, Australia and Japan. Özge Alper's co-authors include Neville F. Hacker, Elke S. Bergmann‐Leitner, Yoon S. Cho‐Chung, Kurt Stromberg, Teresa Bennett, William G. Stetler‐Stevenson, Emma T. Bowden, David S. Salomon, Kurt Stromberg and Scott I. Abrams and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Oncogene.

In The Last Decade

Özge Alper

11 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özge Alper United States 9 200 180 67 64 41 12 365
Manuela Kohler Germany 9 164 0.8× 173 1.0× 69 1.0× 89 1.4× 34 0.8× 11 342
JMS Bartlett United Kingdom 7 186 0.9× 188 1.0× 54 0.8× 82 1.3× 39 1.0× 8 337
Diana P. English United States 14 140 0.7× 232 1.3× 79 1.2× 98 1.5× 43 1.0× 24 447
L. Edwards Australia 7 139 0.7× 142 0.8× 35 0.5× 104 1.6× 73 1.8× 7 363
Laura K. Nolden United States 6 235 1.2× 132 0.7× 21 0.3× 50 0.8× 47 1.1× 7 401
Gabriele Rieck Germany 6 206 1.0× 198 1.1× 19 0.3× 25 0.4× 72 1.8× 8 370
J Sandle United Kingdom 11 146 0.7× 182 1.0× 61 0.9× 8 0.1× 58 1.4× 15 382
Tang Bu-jian China 8 205 1.0× 125 0.7× 11 0.2× 106 1.7× 120 2.9× 15 385
S. G. Shering Ireland 8 175 0.9× 200 1.1× 48 0.7× 9 0.1× 140 3.4× 11 484
Qidan Huang China 12 151 0.8× 118 0.7× 13 0.2× 132 2.1× 85 2.1× 25 430

Countries citing papers authored by Özge Alper

Since Specialization
Citations

This map shows the geographic impact of Özge Alper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özge Alper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özge Alper more than expected).

Fields of papers citing papers by Özge Alper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özge Alper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özge Alper. The network helps show where Özge Alper may publish in the future.

Co-authorship network of co-authors of Özge Alper

This figure shows the co-authorship network connecting the top 25 collaborators of Özge Alper. A scholar is included among the top collaborators of Özge Alper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özge Alper. Özge Alper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Alper, Özge, et al.. (2021). Review of Diabetes Mellitus in Relation to Pancreatic Cancer. 1(1). 1 indexed citations
2.
3.
Rao, Krishna, Özge Alper, Kent E. Opheim, et al.. (2006). Cytogenetic characterization and H-ras associated transformation of immortalized human mammary epithelial cells. Cancer Cell International. 6(1). 15–15. 16 indexed citations
4.
Alper, Özge & Emma T. Bowden. (2005). Novel Insights Into c-Src. Current Pharmaceutical Design. 11(9). 1119–1130. 37 indexed citations
5.
Pack, Svetlana, Özgül M. Alper, Kurt Stromberg, et al.. (2004). Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line. Cancer Research. 64(3). 789–794. 27 indexed citations
6.
Alper, Özge, Elke S. Bergmann‐Leitner, Teresa Bennett, et al.. (2001). Epidermal Growth Factor Receptor Signaling and the Invasive Phenotype of Ovarian Carcinoma Cells. JNCI Journal of the National Cancer Institute. 93(18). 1375–1384. 125 indexed citations
7.
Alper, Özge, Elke S. Bergmann‐Leitner, Scott I. Abrams, & Yoon S. Cho‐Chung. (2001). Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: Protein kinase A downregulation and cytoplasmic export of CRE-binding proteins. Molecular and Cellular Biochemistry. 218(1-2). 55–63. 27 indexed citations
8.
9.
Alper, Özge, Neville F. Hacker, & Yoon S. Cho‐Chung. (1999). Protein kinase A-Iα subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway. Oncogene. 18(35). 4999–5004. 27 indexed citations
10.
Aihara, Miki, Masafumi Shibamori, Kenichi Imagawa, et al.. (1992). In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody. Japanese Journal of Cancer Research. 83(6). 563–567. 5 indexed citations
11.
Alper, Özge, Koji Yamaguchi, Jiro Hitomi, et al.. (1990). The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.. PubMed. 1(12). 591–9. 25 indexed citations
12.
Miyake, Yasuhiro, Koichi Nagasaki, Yasuto Akiyama, et al.. (1990). Parathyroid Hormone-Related Protein in Tumor Tissues Obtained From Patients With Humoral Hypercalcemia of Malignancy. JNCI Journal of the National Cancer Institute. 82(1). 40–44. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuela Kohler Breakdown of academic impact, for papers by JMS Bartlett Breakdown of academic impact, for papers by Diana P. English Breakdown of academic impact, for papers by L. Edwards Breakdown of academic impact, for papers by Laura K. Nolden Breakdown of academic impact, for papers by Gabriele Rieck Breakdown of academic impact, for papers by J Sandle Breakdown of academic impact, for papers by Tang Bu-jian Breakdown of academic impact, for papers by S. G. Shering Breakdown of academic impact, for papers by Qidan Huang
Rankless by CCL
2026